We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New AI Technology Can Determine Best Type of Cancer Treatment

By MedImaging International staff writers
Posted on 23 Jan 2019
Image: New AI technology can help reduce the number of biopsies and surgeries for cancer patients (Photo courtesy of Case Western Reserve University).
Image: New AI technology can help reduce the number of biopsies and surgeries for cancer patients (Photo courtesy of Case Western Reserve University).
A team of researchers from Case Western Reserve University (Cleveland, OH, USA) is using artificial intelligence (AI) and smart-imaging computer technology for viewing routine medical images — MRIs, CAT scans, tissue biopsies — to determine the best type of cancer treatment.

In addition to detecting patterns beyond what the human eye can see, AI and computers can also determine the likelihood that a patient is going to respond to chemotherapy. A significant number of patients receive a cancer diagnosis, but also get over-treated and over-diagnosed. A recent study in the American Journal of Medicine found that 42% of new cancer patients lose their complete life savings in two years for treatment.

The researchers believe that a significant reduction can be brought about in the number of surgeries and of biopsies in patients who do not require them because they have benign nodules. Their research has been able to determine whether breast cancer patients, and more recently lung cancer patients, need chemotherapy. The technology would not reduce the number of jobs for pathologists or radiologists, but assist them and other clinicians.

Related Links:
Case Western Reserve University
X-Ray Illuminator
X-Ray Viewbox Illuminators
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Diagnostic Ultrasound System
DC-80A
Ultrasound Table
Women’s Ultrasound EA Table

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.